COHERUS ONCOLOGY INC (CHRS) — insider trading
Health Care · NASDAQ
COHERUS ONCOLOGY INC (CHRS) has 49 reported SEC Form 4 insider transactions in our data (latest 2026-06-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Newton Charles W. | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Newton Charles W. | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Wahlstrom Mats | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Wahlstrom Mats | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | O'Donnell-Tormey Jill | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | O'Donnell-Tormey Jill | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Ryan Michael Lee | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Ryan Michael Lee | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Newcomer Lee Nisley | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Newcomer Lee Nisley | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Karachun Rita A | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Karachun Rita A | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Satvat Ali J. | Director | Grant / award / vesting (derivative) | 60,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Satvat Ali J. | Director | Grant / award / vesting | 30,000 | $0.00 | $0 | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 225,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 402,500 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 402,500 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 125,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 500,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 500,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 450,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 400,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 200,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 225,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 402,500 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 402,500 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 125,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 500,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 500,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 450,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 400,000 | — | — | Form 4 |
| 2026-05-29 | Lanfear Dennis M | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 200,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 30,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 15,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 100,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 30,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 15,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 25,000 | — | — | Form 4 |
| 2026-05-29 | McMichael Bryan J | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 100,000 | — | — | Form 4 |
| 2026-01-23 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 750,000 | $0.00 | $0 | Form 4 |
| 2026-01-23 | Lanfear Dennis M | Director, Officer (President & CEO) | Grant / award / vesting | 375,000 | $0.00 | $0 | Form 4 |
| 2026-01-22 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 225,000 | $0.00 | $0 | Form 4 |
| 2026-01-22 | McMichael Bryan J | Officer (Chief Financial Officer) | Grant / award / vesting | 112,500 | $0.00 | $0 | Form 4 |
| 2026-01-20 | McMichael Bryan J | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,715 | $1.55 | $2.7K | Form 4 |
Ask the chat about CHRS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: COHERUS ONCOLOGY INC (CHRS).
Last updated 2026-06-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.